格隆汇4月15日丨华兰生物(002007.SZ)在投资者互动平台表示,公司研发的静注人免疫球蛋白(IVIG)(10%)处于III期临床试验阶段。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.